TABLE 3.
Characteristics of Both Trained Models and the Comprised Patients
| Model | Data resources | Number of patients with cancerous tumor in training and validation sets | Number of patients with benign tumor in training and validation sets | Number of patients in test set |
|---|---|---|---|---|
|
Model 1: Benign vs. cancer |
In‐house and public | 75 patients (37 GG = 3, 38 GG = 4 and GG = 5) | 107 patients (benign) |
10 benign 10 GG = 1 10 GG = 2 10 GG = 3 10 GG = 4&5 |
| Model | Data resources | Number of patients with high‐risk tumor in training and validation sets | Number of patients with low‐risk tumor in training and validation sets | Number of patients in test set |
|
Model 2: High‐risk vs. low‐risk |
In‐house and public | 75 patients (37 GG = 3, 38 GG = 4 and GG = 5) | 168 patients (72 GG = 1 and 96 GG = 2) |
10 GG = 1 10 GG = 2 10 GG = 3 10 GG = 4&5 |
GG = Grade Group.